Based in New Zealand, KDI Ingredients is a developer of innovative nutraceutical products and services including ingredient supply, quality and validation, as well as formulation and development.

The Acquisition provides NZCS with immediate access to the lucrative value-added nutraceutical and pharma ingredient sector.

The Acquisition of KDI Ingredients follows the development of a NZCS Collagen Ling Maw nutraceutical product, and is in line with the Company’s strategy to potentially expand revenues streams, by adding greater depth to the existing product line.

This was originally published as an ASX Announcement, which can be found HERE.

Share Price
AUD $0.00
+0.00%
Updated 0/0/00 00:00